4//SEC Filing
Shanafelt Armen 4
Accession 0001209191-21-069351
CIK 0001636282other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 8:41 PM ET
Size
11.1 KB
Accession
0001209191-21-069351
Insider Transaction Report
Form 4
Shanafelt Armen
Director10% Owner
Transactions
- Purchase
Common Stock
2021-12-09$3.67/sh+121,799$446,759→ 121,799 total - Purchase
Common Stock
2021-12-10$3.65/sh+13,516$49,333→ 135,315 total - Purchase
Common Stock
2021-12-13$3.65/sh+14,685$53,600→ 150,000 total
Footnotes (1)
- [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001656151
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 8:41 PM ET
- Size
- 11.1 KB